JVIR, SIR Foundation spotlight studies investigating tumor treatments
JVIR, SIR Foundation spotlight studies investigating tumor treatments
Awards given during Society of Interventional Radiology's Annual Scientific Meeting in Los Angeles
LOS ANGELES, March 20, 2018 /PRNewswire-USNewswire/ -- The Journal of Vascular and Interventional Radiology (JVIR)--the Society of Interventional Radiology's peer-reviewed scientific journal--presented the 2017 JVIR Editor's Best awards during the March 20 general session of the SIR Annual Scientific Meeting, March 17-22 in Los Angeles. The annual awards, supported by SIR Foundation, are made after a comprehensive review of all papers submitted to JVIR during the prior year.
2017 JVIR EDITOR'S AWARD FOR OUTSTANDING CLINICAL STUDY
Etay Ziv, M.D., Ph.D., of the Memorial Sloan Kettering Cancer Center in New York City, was honored with the award for outstanding clinical research paper for "Gene Signature Associated with Upregulation of the Wnt/b-Catenin Signaling Pathway Predicts Tumor Response to Transarterial Embolization."
In citing why this paper stood out, JVIR Editor-in-chief Ziv J Haskal, M.D., FSIR, noted, "This research identified gene mutations and variable sensitivities in tumors treated by interventional radiology with transarterial embolization. It may lead to precision patient care by integrating a patient's genetic marker information into oncologic decision making."
"This type of research is scarce, but it points to a future wherein such markers may prove essential for refining outcomes of IR cancer care," Haskal added.
2017 JVIR EDITOR'S AWARD FOR OUTSTANDING LABORATORY INVESTIGATION
Hideyuki Nishiofuku, M.D., Ph.D., of Nara Medical University in Nara, Japan, was honored with the award for outstanding laboratory investigation for "Intraarterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rabbit Liver Tumor Model."
Haskal noted the importance of this research saying, "SN-38 is the active metabolizing agent of the front-line colon cancer drug, irinotecan. This innovative research describes the ability to effectively craft, load and deliver SN-38 containing nanoparticles to rabbit tumors through their hepatic arteries."
"This research advances a new potential means of targeted chemotherapy delivery for a disease that takes the lives of 50,000 every year in the U.S. alone," Haskal said.
Haskal, a professor with the department of radiology and medical imaging at the University of Virginia Health System in Charlottesville, also recognized the authors of an additional 10 clinical and four laboratory papers for their contributions.
More information about the Society of Interventional Radiology, finding an interventional radiologist in your area, minimally invasive treatments, and the Journal of Vascular and Interventional Radiology can be found online at sirweb.org.
About the Society of Interventional Radiology Foundation
SIR Foundation is a scientific foundation dedicated to fostering research and education in interventional radiology for the purposes of advancing scientific knowledge, increasing the number of skilled investigators in interventional radiology and developing innovative therapies that lead to improved patient care and quality of life. Visit sirfoundation.org.
About the Society of Interventional Radiology
The Society of Interventional Radiology is a nonprofit, professional medical society representing more than 7,500 practicing interventional radiology physicians, trainees, students, scientists and clinical associates, dedicated to improving patient care through the limitless potential of image-guided therapies. SIR's members work in a variety of settings and at different professional levels--from medical students and residents to university faculty and private practice physicians. Visit sirweb.org.
The Society of Interventional Radiology is holding its Annual Scientific Meeting March 17-22, 2018 at the Los Angeles Convention Center in Los Angeles, Calif. Visit sirmeeting.org.
2017 JVIR Editor's Award for Outstanding Clinical Study:
"Gene Signature Associated with Upregulation of the Wnt/b-Catenin Signaling Pathway Predicts Tumor Response to Transarterial Embolization." Ziv E, Yarmohammadi H, Boas FE, Petre EN, Brown KT, Solomon SB, Solit D, Reidy D, Erinjeri JP. J Vasc Interv Radiol 2017, 28: 349-355.
2017 JVIR Editor's Award for Outstanding Laboratory Paper:
"Intraarterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rabbit Liver Tumor Model." Nishiofuku H, Tanaka T, Fukuoka Y, Sato T, Masada T, Tatsumoto S, Sho M, Yamato I, Yasuda S, Matsushima S, Takano M, Ohbayashi C, Kichikawa K. J Vasc Interv Radiol 2017, 28: 457-464
CONTACT: Reporters may obtain both papers by contacting Elise Castelli, (703) 460-5572, ecastelli@sirweb.org, or Kate Martin, (703) 460-5597, kmartin@sirweb.org, in SIR's communications department.
View original content with multimedia:http://www.prnewswire.com/news-releases/jvir-sir-foundation-spotlight-studies-investigating-tumor-treatments-300615675.html
SOURCE Society of Interventional Radiology
